Patents by Inventor Beatriz FERNÁNDEZ MUÑOZ

Beatriz FERNÁNDEZ MUÑOZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11565019
    Abstract: The present invention provides for nanostructured fibrin and agarose hydrogels, preferably type VII agarose hydrogels, (NFAH) or non-nanostructured or pre-nanostructured fibrin and agarose hydrogels, preferably type VII agarose hydrogels, (FAH), as hemostatic agents designed for use as an adjunct or primary treatment in moderate intraoperative hemorrhage and in trauma. These hydrogels can be applied topically to the wound either on the skin in a laparotomy or as non-invasive manner in surgical procedures. Its nanostructure technology generates an adhesive stable fibrin clot required for hemostasis. The attachment properties of the hydrogel, as well as the rapid formation of a fibrin clot, ensures that a strong stable fibrin clot is formed shortly after application.
    Type: Grant
    Filed: April 8, 2019
    Date of Patent: January 31, 2023
    Assignees: FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD, SERVICIO ANDALUZ DE SALUD
    Inventors: Rafael Campos Cuerva, Beatriz Fernandez Muñoz, Miguel Angel Gómez Bravo, Carmen Cepeda Franco, Jordi Muntane Relat
  • Publication number: 20210207089
    Abstract: The present invention provides a novel method to isolate and expand pure neural stem cells (NSCs) from cerebrospinal fluid (CSF) of premature babies with Intraventricular haemorrhage, which produces a population enriched in NSC-CSF cells free of contaminating fibroblasts and other cell types. The present invention also includes substantially pure populations of CSF-NSC cells, and their use to treat and prevent diseases and injuries, including Intraventricular haemorrhage and post-hemorrhage hydrocephalus/developmental deficits.
    Type: Application
    Filed: May 28, 2019
    Publication date: July 8, 2021
    Inventors: Beatriz FERNÁNDEZ MUÑOZ, Rosario SANCHEZ PERNAUTE, Javier MARQUEZ RIVAS, Elena GONZALEZ MUNOZ
  • Publication number: 20210154352
    Abstract: The present invention provides for nanostructured fibrin and agarose hydrogels, preferably type VII agarose hydrogels, (NFAH) or non-nanostructured or pre-nanostructured fibrin and agarose hydrogels, preferably type VII agarose hydrogels, (FAH), as hemostatic agents designed for use as an adjunct or primary treatment in moderate intraoperative hemorrhage and in trauma. These hydrogels can be applied topically to the wound either on the skin in a laparatomy or as non-invasive manner in surgical procedures. Its nanostructure technology generates an adhesive stable fibrin clot required for hemostasis. The attachment properties of the hydrogel, as well as the rapid formation of a fibrin clot, ensures that a strong stable fibrin clot is formed shortly after application.
    Type: Application
    Filed: April 8, 2019
    Publication date: May 27, 2021
    Inventors: Rafael CAMPOS CUERVA, Beatriz FERNANDEZ MUÑOZ, Miguel Angel GÓMEZ BRAVO, Carmen CEPEDA FRANCO, Jordi MUNTANE RELAT